Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis

• Main Authors: Chen-Qian Liu (Author), Jian-Xuan Sun (Author), Jin-Zhou Xu (Author), Xiao-Yuan Qian (Author), Sen-Yuan Hong (Author), Meng-Yao Xu (Author), Ye An (Author), Qi-Dong Xia (Author), Jia Hu (Author), Shao-Gang Wang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The incidence rate and mortality of bladder cancer are increasing year by year. Interestingly, the commonly used metabolic regulatory drug metformin has been reported to have anti-tumor effect in recent years. Nevertheless, it keeps unclear whether the usage of metformin is beneficial or...